First Department of Cardiology
University of Athens, Medical School
Gunjan Gupta, Vijay Kumar Diwana, Kunal Mahajan, Rajesh Chauhan, Saru Thakur
A 15 years old female presented with multiple gradually enlarging nodules over the limbs and buttock region for past 8 years. Patient was mainly concerned about swellings over her feet and hands, as these were so incapacitating that she was unable to do routine tasks ...Read More
Impact of Management Strategies on the Outcome of Persistent Pulmonary Hypertension of the Newborn
Hala Agha, Amira El Tantawy, Iman Iskander, Amany Abdel Samad
Objectives: To evaluate the associated risk factors and to determine the impact of management strategies on the outcome of PPHN.
Study Design: Prospective descriptive study in tertiary center included 40 neonates having PPHN. ...Read More
High Sensitivity Troponin (at 0 & 2 Hrs) in Emergency Department. Will Reducing the Interval Time, Safely Reduce Admissions and Costs?
Background: Every four minutes someone is admitted to hospital suffering from a heart attack or a chest pain event in the UK, totalling over 150,000 hospitalisations a year. Chest pain is one of the most common presentations in the emergency departmen...Read More
Systemic Light Chain Amyloidosis with Cardiac and Renal Involvements in a Patient with Heart Failure
Cong Zhang, Hongxing Luo, Yu Xu
Amyloidosis is a protein-folding disorder with more than one organ infiltrated by proteinaceous deposits, the clinical syndromes and the management strategies of the disease are determined both by the organs involved and the type of amyloidosis. In light-chain amyloid...Read More
Genetic Variability within the ADA Gene and Left Ventricular Ejection Fraction
Gloria-Bottini F, Banci M, Neri A, Magrini A, Bottini E
Background: The role of adenosine as cardio protective factor is well established. Adenosine deaminase (ADA) contributes to the control of adenosine concentration in body fluids and, as ecto-enzyme, to the regulation of adenosine receptors activity. ADA and adenosine receptors ex...Read More
Cancer Therapy-Induced Cardiotoxicity: Where are We Now?
Pierre A. Guertin
Cardiotoxicity effects, cardiovascular diseases (CVDs), and hypertension occurring months to several years postchemotherapy and/or radiotherapy are well-recognized by experts. Anthracyclines were found in the late 1960s to be dose-dependently associated with induced-c...Read More